These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Early treatment of acute biliary pancreatitis by endoscopic papillotomy. Fan ST; Lai EC; Mok FP; Lo CM; Zheng SS; Wong J N Engl J Med; 1993 Jan; 328(4):228-32. PubMed ID: 8418402 [TBL] [Abstract][Full Text] [Related]
24. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477 [TBL] [Abstract][Full Text] [Related]
25. Frequency and risk factors in the post-ERCP pancreatitis in a tertiary care centre. Leghari A; Ghazanfar S; Qureshi S; Taj MA; Niaz SK; Quraishy MS J Coll Physicians Surg Pak; 2013 Sep; 23(9):620-4. PubMed ID: 24034184 [TBL] [Abstract][Full Text] [Related]
26. A simple way of avoiding post-ERCP pancreatitis. Lella F; Bagnolo F; Colombo E; Bonassi U Gastrointest Endosc; 2004 Jun; 59(7):830-4. PubMed ID: 15173796 [TBL] [Abstract][Full Text] [Related]
27. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines. Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for post-ERCP pancreatitis and hyperamylasemia: A retrospective single-center study. He QB; Xu T; Wang J; Li YH; Wang L; Zou XP J Dig Dis; 2015 Aug; 16(8):471-8. PubMed ID: 25955444 [TBL] [Abstract][Full Text] [Related]
29. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247 [TBL] [Abstract][Full Text] [Related]
30. Risk factors for complications of ERCP in primary sclerosing cholangitis. Ismail S; Kylänpää L; Mustonen H; Halttunen J; Lindström O; Jokelainen K; Udd M; Färkkilä M Endoscopy; 2012 Dec; 44(12):1133-8. PubMed ID: 23108808 [TBL] [Abstract][Full Text] [Related]
31. Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial. Uchino R; Isayama H; Tsujino T; Sasahira N; Ito Y; Matsubara S; Takahara N; Arizumi T; Toda N; Mohri D; Togawa O; Yagioka H; Yanagihara Y; Nakajima K; Akiyama D; Hamada T; Miyabayashi K; Mizuno S; Kawakubo K; Kogure H; Sasaki T; Yamamoto N; Nakai Y; Hirano K; Tada M; Koike K Gastrointest Endosc; 2013 Dec; 78(6):842-850. PubMed ID: 23910063 [TBL] [Abstract][Full Text] [Related]
33. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959 [TBL] [Abstract][Full Text] [Related]
34. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Freeman ML; DiSario JA; Nelson DB; Fennerty MB; Lee JG; Bjorkman DJ; Overby CS; Aas J; Ryan ME; Bochna GS; Shaw MJ; Snady HW; Erickson RV; Moore JP; Roel JP Gastrointest Endosc; 2001 Oct; 54(4):425-34. PubMed ID: 11577302 [TBL] [Abstract][Full Text] [Related]
35. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail. Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246 [TBL] [Abstract][Full Text] [Related]
36. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. Milewski J; Rydzewska G; Degowska M; Kierzkiewicz M; Rydzewski A World J Gastroenterol; 2006 Jun; 12(23):3751-5. PubMed ID: 16773694 [TBL] [Abstract][Full Text] [Related]
37. Direct spraying of shakuyakukanzoto onto the duodenal papilla: a novel method for preventing pancreatitis following endoscopic retrograde cholangiopancreatography. Fujinami H; Kajiura S; Ando T; Mihara H; Hosokawa A; Sugiyama T Digestion; 2015; 91(1):42-5. PubMed ID: 25632916 [TBL] [Abstract][Full Text] [Related]
38. Urgent ERCP with pancreatic stent placement or replacement for salvage of post-ERCP pancreatitis. Kerdsirichairat T; Attam R; Arain M; Bakman Y; Radosevich D; Freeman M Endoscopy; 2014 Dec; 46(12):1085-94. PubMed ID: 25216326 [TBL] [Abstract][Full Text] [Related]